This announcement is a separate document:
金陵药业：江苏泰和律师事务所关于金陵药业股份有限公司2023年度向特定对象发行A股股票发行过程和认购对象合规性的法律意见书
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on the issuance process of Jinling Pharmaceutical Co., Ltd. to issue A shares to specific targets in 2023 and compliance with subscription targets
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.